← All diseases
Cancer
Multiple myeloma
Do you want to receive a message when there is new research about Multiple myeloma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you receive a notification as soon as there is new research about Multiple myeloma. View what Premium costs.
Publications and studies (2183)
- Design and Rationale of Prolonged Nightly Fasting for Multiple Myeloma Prevention (PROFAST): Protocol for a Randomized Controlled Pilot Trial. (2024/03/11) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Large differences in age-specific survival in multiple myeloma in the Nordic countries. (2024/03/11) ♡
- Essential role of local antibody distribution in mediating bone-resorbing effects. (2024/03/07) ♡
- Adherence to the evidence-based recommendations in managing bone health, pain, and mobility of patients with multiple myeloma: a mixed method in the Palestinian healthcare system. (2024/03/05) ♡
- Immunocytochemistry on frozen-embedded cell block for the diagnosis of hematolymphoid cytology specimen: a straightforward alternative to the conventional cell block. (2024/03/01) ♡
- Multiple Myeloma: Validation of the Values and Preferences Elicitation Questionnaire- Cure and Survival Preference Scale (VPEQ-CSPS). (2024/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Predictive and prognostic molecular biomarkers in lymphomas. (2024/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. BCMA-directed therapy, new treatments in the myeloma toolbox, and how to use them. (2024/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Solitary ovarian plasmacytoma: About a rare entity of extramedullary plasma cell tumor. (2024/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Elevated Osmolal Gap in a Case of Multiple Myeloma. (2024/03/01) ♡
- Seven-year Follow-up of India's First Sequential Hematopoietic Stem Cell and Kidney Transplant for Multiple Myeloma. (2024/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Genome-wide analysis in PC6 electroacupuncture to ameliorate carfilzomib-induced cardiotoxicity in mice. (2024/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Teclistamab-cqyv in multiple myeloma. (2024/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges. (2024/03/01) ♡
- The Prognostic Significance of Vitamin D Deficiency in Korean Patients With Multiple Myeloma. (2024/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Selinexor in multiple myeloma. (2024/03/01) ♡
- Are the GLIM Criteria Guiding in the Course of Hematological Malignancies? (2024/03/01) ♡
- Cancer risk according to fasting blood glucose trajectories: a population-based cohort study. (2024/02/27) ♡
- Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity. (2024/02/27) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A 50-Year-Old Man Presenting with Multiple Bone Lesions and a Diagnosis of Phosphaturic Mesenchymal Tumor of the Femur. (2024/02/16) ♡
- Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population. (2024/02/13) ♡
- Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myeloma. (2024/02/13) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An overview of multiple myeloma: A monoclonal plasma cell malignancy's diagnosis, management, and treatment modalities. (2024/02/01) ♡
- Vitamin D and monoclonal gammopathy of undetermined significance (MGUS) among U.S. Black women. (2024/02/01) ♡
- Comparison of pre- and posttransplant energy expenditure in patients undergoing hematopoietic stem cell transplantation and evaluation of associated factors. (2024/02/01) ♡
- Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study. (2024/02/01) ♡
- [Effects of Pre-Transplant CONUT and Post-Transplant MRD on Prognosis of Patients with Multiple Myeloma after Auto-HSCT]. (2024/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe hypertriglyceridaemia and hypervitaminosis D secondary to multiple myeloma. (2024/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Case report: Refractory Evans syndrome in two patients with spondyloenchondrodysplasia with immune dysregulation treated successfully with JAK1/JAK2 inhibition. (2024/01/29) ♡
- ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells. (2024/01/29) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Genome-wide CRISPR/Cas9 screen identifies regulators of BCMA expression on multiple myeloma cells. (2024/01/25) ♡
- On-demand plerixafor added to high-dose cyclophosphamide and pegylated recombinant human granulocyte colony-stimulating factor in the mobilization of patients with multiple myeloma: a treatment with high effectiveness, convenient, and affordable cost. (2024/01/17) ♡
- Myxoma Virus Combination Therapy Enhances Lenalidomide and Bortezomib Treatments for Multiple Myeloma. (2024/01/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Conceptualizing an Integrative Multiple Myeloma Care: The Role of Nutrition, Supplements, and Complementary Modalities. (2024/01/11) ♡
- Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation. (2024/01/09) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe haemorrhagic diathesis due to acquired hypofibrinogenemia in a patient with early T-cell precursor acute lymphoblastic leukaemia/lymphoma: a case report. (2024/01/08) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019. (2024/01/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy. (2024/01/06) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions. (2024/01/02) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Oxyphenbutazone ameliorates carfilzomib induced cardiotoxicity in rats via inhibition of oxidative free radical burst and NF-κB/IκB-α pathway. (2024/01/01) ♡
- Relapsed Multiple Myeloma with Anaplastic Transformation. (2024/01/01) ♡
- Potential Clinical Role of LncRNA miR503HG in Multiple Myeloma and its Effect on the Proliferation and Adhesion of Myeloma Cells. (2024/01/01) ♡
- COVID-19 Vaccine Uptake in Patients with Multiple Myeloma and AL Amyloidosis: A Cross-Sectional Observational Study from India. (2024/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Median Sternotomy as a Useful Adjunct to Anterior Cervicothoracic Spine Decompression and Fixation: A Plea for Its Popularity among Spine Surgeons in West Africa. (2024/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Myelomatous pleural effusion in multiple myeloma- A rare presentation. (2024/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Extramedullary plasmacytoma of the larynx - Case report. (2024/01/01) ♡
- Multiple Facets of Multiple Myeloma in Kidney Biopsy: A Multicenter Retrospective Study. (2024/01/01) ♡
- Inhibition of Myeloma Cell Function by Cannabinoid-Enriched Product Associated With Regulation of Telomere and TP53. (2024/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials. (2024/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report on a Multidisciplinary Approach to Address Malnutrition and Improve a Patient's Fitness for Treatment. (2024/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.